EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Differential Effects of Antifibrotic Treatment on Outcome Prediction via Serial Matrix Metalloproteinase-Degraded C-Reactive Protein Neoepitope Levels in Idiopathic Pulmonary Fibrosis

Benjamin Seeliger, Jannik Ruwisch, Jannie Marie Bülow Sand, Filipa B Simões, Henrik Jessen, Eda Börner, Jan Fuge, Katherina Sewald, Tobias Welte, Pedro David Wendel-Garcia, Jonas C Schupp, Diana Julie Leeming und 2 weitere

CHEST · 2026

DOI: 10.1016/j.chest.2025.08.047 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift CHEST, 2026. Verfasst von Benjamin Seeliger und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany; Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Pyridones, Indoles, C-Reactive Protein. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Fritz Thyssen Stiftung, Medizinischen Hochschule Hannover.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is characterized by an increase in proteolytic enzymes, including matrix metalloproteinases that degrade the extracellular matrix and markers of localized inflammation. Protein fragments (neoepitopes) are detectable in the circulation. RESEARCH QUESTION: Can short-term trajectories of neoepitopes after initiation of antifibrotic treatment predict therapy-related outcomes, including mortality, in patients with IPF? STUDY DESIGN AND METHODS: Two hundred three treatment-naive patients with IPF from 2 German tertiary centers were prospectively recruited. At baseline and within 6 months of nintedanib or pirfenidone treatment, serum concentrations of matrix metalloproteinase-degraded C-reactive protein neoepitope (CRPM), collagen III, and collagen 6 fragments, as well as procollagen 6, were measured. Association of neoepitopes and their longitudinal kinetics (positive/increasing or negative/declining slope) with mortality and progression- and transplant-free survival (PTFS) was analyzed. Modes of action of anti-fibrotic therapy on neoepitope kinetics were further investigated by cell culture experiments. RESULTS: Patient mean age was 71 years, and 20.7% were female. After baseline measurements, 50% received nintedanib, 35% received pirfenidone, and 15% received no antifibrotic treatment. Patients with a positive CRPM slope, treated with nintedanib, showed increased 5-year mortality (adjusted hazard ratio, 2.27; P = .020). In contrast, PTFS was significantly reduced with positive slopes of all tested neoepitopes. The association between positive CRPM slopes and impaired PTFS was confirmed by means of propensity score matching. In both cohorts, effects on PTFS were driven by the nintedanib-treated subcohort. Intercohort validation of the association between CRPM slopes and PTFS was evident. In cell-culture experiments, nintedanib exclusively modulated CRPM kinetics in human umbilical vein-derived endothelial cells, but not IPF-derived fibroblasts. This suggests that the observed nintedanib/CRPM related effect is partly mediated by endothelial cells. INTERPRETATION: Our results show that positive/increasing CRPM serum levels (slopes) were associated with worse 5-year survival in patients with IPF treated with nintedanib, but not pirfenidone. Nintedanib, but not pirfenidone, reduced endothelial CRPM formation in vitro. GERMAN CLINICAL TRIALS REGISTRATION: Nos.: DRKS00000017 and DRKS00000620; URL: https://drks.de/search/en/trial/.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisPyridonesIndolesC-Reactive ProteinEpitopesMatrix MetalloproteinasesAntifibrotic AgentsHumansFemaleAgedMaleProspective StudiesBiomarkersMiddle AgedGermany

Stichwörter der Autor:innen

antifibroticbiomarkercollagenidiopathic pulmonary fibrosisneoepitopesprogressive pulmonary fibrosis

Substanzen

nintedanibPyridonespirfenidoneIndolesC-Reactive ProteinBiomarkersEpitopesMatrix MetalloproteinasesAntifibrotic Agents

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany; Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH), Hannover Medical School (MHH), German Center for Lung Research (DZL…
  • Nordic Bioscience A/S, Biomarkers and Research, Herlev, Denmark.
  • Center for Interstitial and Rare Lung Diseases, Ruhrlandklinik, Pneumonology Department, University of Duisburg-Essen, Essen, Germany.
  • Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
  • Division of Cardiothoracic Anesthesia and Intensive Care Medicine, Department of General Anesthesia, Intensive Care and Pain Medicine, Medical University Vienna, Vienna, Austria; Institute of Intensive Care Medicine, Un…

Förderung

  • Deutsche Forschungsgemeinschaft
  • Fritz Thyssen Stiftung
  • Medizinischen Hochschule Hannover
  • Deutsches Zentrum fur Lungenforschung e V

Zitieren

APA

Seeliger, B., Ruwisch, J., Bülow Sand, J. M., Simões, F. B., Jessen, H., Börner, E., Fuge, J., Sewald, K., Welte, T., Wendel-Garcia, P. D., Schupp, J. C., Leeming, D. J., Bonella, F., & Prasse, A. (2026). Differential Effects of Antifibrotic Treatment on Outcome Prediction via Serial Matrix Metalloproteinase-Degraded C-Reactive Protein Neoepitope Levels in Idiopathic Pulmonary Fibrosis. CHEST. https://doi.org/10.1016/j.chest.2025.08.047

Vancouver

Seeliger B, Ruwisch J, Bülow Sand JM, Simões FB, Jessen H, Börner E, et al. Differential Effects of Antifibrotic Treatment on Outcome Prediction via Serial Matrix Metalloproteinase-Degraded C-Reactive Protein Neoepitope Levels in Idiopathic Pulmonary Fibrosis. CHEST. 2026. doi:10.1016/j.chest.2025.08.047

BibTeX
@article{Seeliger2026,
  author = {Seeliger, Benjamin and Ruwisch, Jannik and Bülow Sand, Jannie Marie and Simões, Filipa B and Jessen, Henrik and Börner, Eda and Fuge, Jan and Sewald, Katherina and Welte, Tobias and Wendel-Garcia, Pedro David and Schupp, Jonas C and Leeming, Diana Julie and Bonella, Francesco and Prasse, Antje},
  title = {Differential Effects of Antifibrotic Treatment on Outcome Prediction via Serial Matrix Metalloproteinase-Degraded C-Reactive Protein Neoepitope Levels in Idiopathic Pulmonary Fibrosis},
  journal = {CHEST},
  year = {2026},
  doi = {10.1016/j.chest.2025.08.047}
}
Kostenlos starten →